Here, we used a combination of scRNAseq, scTCRseq, and proteomics to identify the CSF and blood immune correlates of chronic neuroinflammation in MS, defined by the presence of PRL as a radiological biomarker associated with disability accumulation and progression. Here, PRL is linked to myeloid sarcoma.